期刊文献+

对肺癌患者进行SF、CEA、NSE、CYFRA21-1及CA125联合检测的临床价值

下载PDF
导出
摘要 目的:探讨对肺癌患者进行铁蛋白(SF)、癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、细胞角蛋白19片段抗原(CYFRA21-1)与糖类抗原(CA125)联合检测的临床价值。方法:将近年来我院收治的85例肺癌患者作为观察组,将同期我院收治的85例肺部良性病变患者作为对照组,对两组患者分别进行SF、CEA、NSE、CYFR21-1及CA125检测,然后对比分析其检测结果。结果:观察组患者SF、CEA、NSE、CYFRA21-1及CA125的含量均高于对照组患者,差异有统计学意义(P<0.05)。与进行单项血清肿瘤标志物检测相比,对观察组患者进行5项血清肿瘤标志物联合检测在诊断其病情方面的敏感度与特异性均较高。结论:采用SF、CEA、NSE、CYFRA21-1及CA125联合检测法对早期肺癌进行诊断的准确率较高,此法值得在临床上推广应用。
作者 李海霞
出处 《当代医药论丛》 2016年第21期116-117,共2页
  • 引文网络
  • 相关文献

参考文献2

二级参考文献25

  • 1李欣,赵建平,楼雅芳,陈慧,朱丹,朱景倩,涂军伟.血清肿瘤标记物系列检测对肺癌的临床诊断价值[J].浙江医学,2006,28(3):180-183. 被引量:4
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics,2009 [ J ] . CACancer J Clin, 2009,59(4) :225 -249.
  • 3Undemer M,Urban T,Perriot J,et al. Cannabis smoking and lungcancer[ J]. Rev Mai Respir,2014,31(6) :488 -498.
  • 4Goffin J,Lacchetti C,Ellis PM,et al. First-line systemic chemother-apy in the treatment of advanced non-small cell lung cancer : a sys-tematic review[ J]. J Thorac Oncol, 2010,5(2) :260 -274.
  • 5Behera M,Owonikoko TK,Chen Z,et al. Single agent maintenancetherapy for advanced stage non-small cell lung cancer : a meta-anal-ysis[ J]. Lung Cancer, 2012,77(2) :331 -338.
  • 6Molina R, Aug6 JM, Bosch X, et al. Usefulness of serum tumormarkers,including progastrin-releasing peptide,in patients withlung cancer: correlation with histology [ J ] . Tumour Biol,2009,30(3):121 -129.
  • 7Ransohoff DF. Rules of evidence for cancer molecular-marker dis-covery and validation [ J ]. Nat Rev Cancer, 2004 , 4 ( 4): 309-314.
  • 8Hammond ME,Taube SE. Issues and barriers to development of clini-cally useful tumor markers : a development pathway proposal [ J ].Semin Oncol, 2002,29(3) :213 -221.
  • 9Mao Q,Zhang Y,Fu X,et al. A tumor hypoxic niche protects hu-man colon cancer stem cells from chemotherapy [ J ]. J Cancer ResClin Oncol, 2013,139(2) :211 -222.
  • 10Semenza GL. HIF-1 mediates metabolic responses to intratumoralhypoxia and oncogenic mutations [ J ]. J Clin Invest, 2013,123(9):3664-3671.

共引文献30

;
使用帮助 返回顶部